The global Covid-19 Diagnostic market size was valued at US$ million in 2023. With growing demand in downstream market, the Covid-19 Diagnostic is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Covid-19 Diagnostic market. Covid-19 Diagnostic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Covid-19 Diagnostic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Covid-19 Diagnostic market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Covid-19 Diagnostic market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Covid-19 Diagnostic market. It may include historical data, market segmentation by Type (e.g., Immunoassay, Genomic and WGS Role), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Covid-19 Diagnostic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Covid-19 Diagnostic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Covid-19 Diagnostic industry. This include advancements in Covid-19 Diagnostic technology, Covid-19 Diagnostic new entrants, Covid-19 Diagnostic new investment, and other innovations that are shaping the future of Covid-19 Diagnostic.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Covid-19 Diagnostic market. It includes factors influencing customer ' purchasing decisions, preferences for Covid-19 Diagnostic product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Covid-19 Diagnostic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Covid-19 Diagnostic market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Covid-19 Diagnostic market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Covid-19 Diagnostic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Covid-19 Diagnostic market.
Market Segmentation:
Covid-19 Diagnostic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Immunoassay
Genomic and WGS Role
rRT-PCR
Segmentation by application
Hospital
Laboratory
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Diagnostics
Accelerate Diagnostics
Ador Diagnostics
Akkoni Biosystems
Alveo Technologies
Applied BioCode
Aus Diagnostics
BD Diagnostics
Biocartis
BioFire Diagnostics
²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ
Bio-Rad Laboratories
Bosch Healthcare Solutions GmbH
Cepheid
Co-Diagnostics
Cue Health
Curetis
Diagenode Diagnostics
Diascopic
Diasorin
Expedeon
Fusion Genomics.
GenePOC Diagnostics
GenMark Dx
Hologic
Immunexpress
Inflammatix
Invetech
Janssen Diagnostics
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Covid-19 Diagnostic Market Size 2019-2030
2.1.2 Covid-19 Diagnostic Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Covid-19 Diagnostic Segment by Type
2.2.1 Immunoassay
2.2.2 Genomic and WGS Role
2.2.3 rRT-PCR
2.3 Covid-19 Diagnostic Market Size by Type
2.3.1 Covid-19 Diagnostic Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Covid-19 Diagnostic Market Size Market Share by Type (2019-2024)
2.4 Covid-19 Diagnostic Segment by Application
2.4.1 Hospital
2.4.2 Laboratory
2.5 Covid-19 Diagnostic Market Size by Application
2.5.1 Covid-19 Diagnostic Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Covid-19 Diagnostic Market Size Market Share by Application (2019-2024)
3 Covid-19 Diagnostic Market Size by Player
3.1 Covid-19 Diagnostic Market Size Market Share by Players
3.1.1 Global Covid-19 Diagnostic Revenue by Players (2019-2024)
3.1.2 Global Covid-19 Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Covid-19 Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Covid-19 Diagnostic by Regions
4.1 Covid-19 Diagnostic Market Size by Regions (2019-2024)
4.2 Americas Covid-19 Diagnostic Market Size Growth (2019-2024)
4.3 APAC Covid-19 Diagnostic Market Size Growth (2019-2024)
4.4 Europe Covid-19 Diagnostic Market Size Growth (2019-2024)
4.5 Middle East & Africa Covid-19 Diagnostic Market Size Growth (2019-2024)
5 Americas
5.1 Americas Covid-19 Diagnostic Market Size by Country (2019-2024)
5.2 Americas Covid-19 Diagnostic Market Size by Type (2019-2024)
5.3 Americas Covid-19 Diagnostic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Covid-19 Diagnostic Market Size by Region (2019-2024)
6.2 APAC Covid-19 Diagnostic Market Size by Type (2019-2024)
6.3 APAC Covid-19 Diagnostic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Covid-19 Diagnostic by Country (2019-2024)
7.2 Europe Covid-19 Diagnostic Market Size by Type (2019-2024)
7.3 Europe Covid-19 Diagnostic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Covid-19 Diagnostic by Region (2019-2024)
8.2 Middle East & Africa Covid-19 Diagnostic Market Size by Type (2019-2024)
8.3 Middle East & Africa Covid-19 Diagnostic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Covid-19 Diagnostic Market Forecast
10.1 Global Covid-19 Diagnostic Forecast by Regions (2025-2030)
10.1.1 Global Covid-19 Diagnostic Forecast by Regions (2025-2030)
10.1.2 Americas Covid-19 Diagnostic Forecast
10.1.3 APAC Covid-19 Diagnostic Forecast
10.1.4 Europe Covid-19 Diagnostic Forecast
10.1.5 Middle East & Africa Covid-19 Diagnostic Forecast
10.2 Americas Covid-19 Diagnostic Forecast by Country (2025-2030)
10.2.1 United States Covid-19 Diagnostic Market Forecast
10.2.2 Canada Covid-19 Diagnostic Market Forecast
10.2.3 Mexico Covid-19 Diagnostic Market Forecast
10.2.4 Brazil Covid-19 Diagnostic Market Forecast
10.3 APAC Covid-19 Diagnostic Forecast by Region (2025-2030)
10.3.1 China Covid-19 Diagnostic Market Forecast
10.3.2 Japan Covid-19 Diagnostic Market Forecast
10.3.3 Korea Covid-19 Diagnostic Market Forecast
10.3.4 Southeast Asia Covid-19 Diagnostic Market Forecast
10.3.5 India Covid-19 Diagnostic Market Forecast
10.3.6 Australia Covid-19 Diagnostic Market Forecast
10.4 Europe Covid-19 Diagnostic Forecast by Country (2025-2030)
10.4.1 Germany Covid-19 Diagnostic Market Forecast
10.4.2 France Covid-19 Diagnostic Market Forecast
10.4.3 UK Covid-19 Diagnostic Market Forecast
10.4.4 Italy Covid-19 Diagnostic Market Forecast
10.4.5 Russia Covid-19 Diagnostic Market Forecast
10.5 Middle East & Africa Covid-19 Diagnostic Forecast by Region (2025-2030)
10.5.1 Egypt Covid-19 Diagnostic Market Forecast
10.5.2 South Africa Covid-19 Diagnostic Market Forecast
10.5.3 Israel Covid-19 Diagnostic Market Forecast
10.5.4 Turkey Covid-19 Diagnostic Market Forecast
10.5.5 GCC Countries Covid-19 Diagnostic Market Forecast
10.6 Global Covid-19 Diagnostic Forecast by Type (2025-2030)
10.7 Global Covid-19 Diagnostic Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Information
11.1.2 Abbott Diagnostics Covid-19 Diagnostic Product Offered
11.1.3 Abbott Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Diagnostics Main Business Overview
11.1.5 Abbott Diagnostics Latest Developments
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Information
11.2.2 Accelerate Diagnostics Covid-19 Diagnostic Product Offered
11.2.3 Accelerate Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Accelerate Diagnostics Main Business Overview
11.2.5 Accelerate Diagnostics Latest Developments
11.3 Ador Diagnostics
11.3.1 Ador Diagnostics Company Information
11.3.2 Ador Diagnostics Covid-19 Diagnostic Product Offered
11.3.3 Ador Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Ador Diagnostics Main Business Overview
11.3.5 Ador Diagnostics Latest Developments
11.4 Akkoni Biosystems
11.4.1 Akkoni Biosystems Company Information
11.4.2 Akkoni Biosystems Covid-19 Diagnostic Product Offered
11.4.3 Akkoni Biosystems Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Akkoni Biosystems Main Business Overview
11.4.5 Akkoni Biosystems Latest Developments
11.5 Alveo Technologies
11.5.1 Alveo Technologies Company Information
11.5.2 Alveo Technologies Covid-19 Diagnostic Product Offered
11.5.3 Alveo Technologies Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Alveo Technologies Main Business Overview
11.5.5 Alveo Technologies Latest Developments
11.6 Applied BioCode
11.6.1 Applied BioCode Company Information
11.6.2 Applied BioCode Covid-19 Diagnostic Product Offered
11.6.3 Applied BioCode Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Applied BioCode Main Business Overview
11.6.5 Applied BioCode Latest Developments
11.7 Aus Diagnostics
11.7.1 Aus Diagnostics Company Information
11.7.2 Aus Diagnostics Covid-19 Diagnostic Product Offered
11.7.3 Aus Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Aus Diagnostics Main Business Overview
11.7.5 Aus Diagnostics Latest Developments
11.8 BD Diagnostics
11.8.1 BD Diagnostics Company Information
11.8.2 BD Diagnostics Covid-19 Diagnostic Product Offered
11.8.3 BD Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BD Diagnostics Main Business Overview
11.8.5 BD Diagnostics Latest Developments
11.9 Biocartis
11.9.1 Biocartis Company Information
11.9.2 Biocartis Covid-19 Diagnostic Product Offered
11.9.3 Biocartis Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Biocartis Main Business Overview
11.9.5 Biocartis Latest Developments
11.10 BioFire Diagnostics
11.10.1 BioFire Diagnostics Company Information
11.10.2 BioFire Diagnostics Covid-19 Diagnostic Product Offered
11.10.3 BioFire Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 BioFire Diagnostics Main Business Overview
11.10.5 BioFire Diagnostics Latest Developments
11.11 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ
11.11.1 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Company Information
11.11.2 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Covid-19 Diagnostic Product Offered
11.11.3 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Main Business Overview
11.11.5 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Latest Developments
11.12 Bio-Rad Laboratories
11.12.1 Bio-Rad Laboratories Company Information
11.12.2 Bio-Rad Laboratories Covid-19 Diagnostic Product Offered
11.12.3 Bio-Rad Laboratories Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Bio-Rad Laboratories Main Business Overview
11.12.5 Bio-Rad Laboratories Latest Developments
11.13 Bosch Healthcare Solutions GmbH
11.13.1 Bosch Healthcare Solutions GmbH Company Information
11.13.2 Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Product Offered
11.13.3 Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Bosch Healthcare Solutions GmbH Main Business Overview
11.13.5 Bosch Healthcare Solutions GmbH Latest Developments
11.14 Cepheid
11.14.1 Cepheid Company Information
11.14.2 Cepheid Covid-19 Diagnostic Product Offered
11.14.3 Cepheid Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Cepheid Main Business Overview
11.14.5 Cepheid Latest Developments
11.15 Co-Diagnostics
11.15.1 Co-Diagnostics Company Information
11.15.2 Co-Diagnostics Covid-19 Diagnostic Product Offered
11.15.3 Co-Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Co-Diagnostics Main Business Overview
11.15.5 Co-Diagnostics Latest Developments
11.16 Cue Health
11.16.1 Cue Health Company Information
11.16.2 Cue Health Covid-19 Diagnostic Product Offered
11.16.3 Cue Health Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Cue Health Main Business Overview
11.16.5 Cue Health Latest Developments
11.17 Curetis
11.17.1 Curetis Company Information
11.17.2 Curetis Covid-19 Diagnostic Product Offered
11.17.3 Curetis Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Curetis Main Business Overview
11.17.5 Curetis Latest Developments
11.18 Diagenode Diagnostics
11.18.1 Diagenode Diagnostics Company Information
11.18.2 Diagenode Diagnostics Covid-19 Diagnostic Product Offered
11.18.3 Diagenode Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Diagenode Diagnostics Main Business Overview
11.18.5 Diagenode Diagnostics Latest Developments
11.19 Diascopic
11.19.1 Diascopic Company Information
11.19.2 Diascopic Covid-19 Diagnostic Product Offered
11.19.3 Diascopic Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Diascopic Main Business Overview
11.19.5 Diascopic Latest Developments
11.20 Diasorin
11.20.1 Diasorin Company Information
11.20.2 Diasorin Covid-19 Diagnostic Product Offered
11.20.3 Diasorin Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Diasorin Main Business Overview
11.20.5 Diasorin Latest Developments
11.21 Expedeon
11.21.1 Expedeon Company Information
11.21.2 Expedeon Covid-19 Diagnostic Product Offered
11.21.3 Expedeon Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Expedeon Main Business Overview
11.21.5 Expedeon Latest Developments
11.22 Fusion Genomics.
11.22.1 Fusion Genomics. Company Information
11.22.2 Fusion Genomics. Covid-19 Diagnostic Product Offered
11.22.3 Fusion Genomics. Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Fusion Genomics. Main Business Overview
11.22.5 Fusion Genomics. Latest Developments
11.23 GenePOC Diagnostics
11.23.1 GenePOC Diagnostics Company Information
11.23.2 GenePOC Diagnostics Covid-19 Diagnostic Product Offered
11.23.3 GenePOC Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 GenePOC Diagnostics Main Business Overview
11.23.5 GenePOC Diagnostics Latest Developments
11.24 GenMark Dx
11.24.1 GenMark Dx Company Information
11.24.2 GenMark Dx Covid-19 Diagnostic Product Offered
11.24.3 GenMark Dx Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 GenMark Dx Main Business Overview
11.24.5 GenMark Dx Latest Developments
11.25 Hologic
11.25.1 Hologic Company Information
11.25.2 Hologic Covid-19 Diagnostic Product Offered
11.25.3 Hologic Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 Hologic Main Business Overview
11.25.5 Hologic Latest Developments
11.26 Immunexpress
11.26.1 Immunexpress Company Information
11.26.2 Immunexpress Covid-19 Diagnostic Product Offered
11.26.3 Immunexpress Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.26.4 Immunexpress Main Business Overview
11.26.5 Immunexpress Latest Developments
11.27 Inflammatix
11.27.1 Inflammatix Company Information
11.27.2 Inflammatix Covid-19 Diagnostic Product Offered
11.27.3 Inflammatix Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.27.4 Inflammatix Main Business Overview
11.27.5 Inflammatix Latest Developments
11.28 Invetech
11.28.1 Invetech Company Information
11.28.2 Invetech Covid-19 Diagnostic Product Offered
11.28.3 Invetech Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.28.4 Invetech Main Business Overview
11.28.5 Invetech Latest Developments
11.29 Janssen Diagnostics
11.29.1 Janssen Diagnostics Company Information
11.29.2 Janssen Diagnostics Covid-19 Diagnostic Product Offered
11.29.3 Janssen Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.29.4 Janssen Diagnostics Main Business Overview
11.29.5 Janssen Diagnostics Latest Developments
12 Research Findings and Conclusion
Ìý
Ìý
*If Applicable.
